CATALOGO DEI PRODOTTI DELLA RICERCA

BELLINATO, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.061
EU - Europa 4.013
AS - Asia 3.050
SA - Sud America 503
AF - Africa 201
Continente sconosciuto - Info sul continente non disponibili 150
OC - Oceania 47
Totale 12.025
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.932
RU - Federazione Russa 1.764
SG - Singapore 1.376
IT - Italia 899
CN - Cina 507
BR - Brasile 400
HK - Hong Kong 300
VN - Vietnam 269
DE - Germania 243
GB - Regno Unito 222
IE - Irlanda 163
FI - Finlandia 145
SE - Svezia 140
FR - Francia 116
KR - Corea 98
BD - Bangladesh 94
NL - Olanda 79
IN - India 76
ID - Indonesia 68
CA - Canada 61
TR - Turchia 59
ES - Italia 57
TG - Togo 47
NG - Nigeria 44
JP - Giappone 43
MX - Messico 43
AU - Australia 41
BJ - Benin 40
PL - Polonia 35
AR - Argentina 32
ZA - Sudafrica 27
AT - Austria 25
IQ - Iraq 20
CH - Svizzera 19
EC - Ecuador 19
SA - Arabia Saudita 18
IR - Iran 17
MY - Malesia 17
CL - Cile 15
UA - Ucraina 15
PH - Filippine 12
PK - Pakistan 12
CO - Colombia 10
DK - Danimarca 10
HR - Croazia 10
UZ - Uzbekistan 9
BE - Belgio 8
DZ - Algeria 8
TN - Tunisia 8
VE - Venezuela 8
JO - Giordania 7
NP - Nepal 7
PT - Portogallo 7
RO - Romania 7
UY - Uruguay 7
EG - Egitto 6
GR - Grecia 6
JM - Giamaica 6
MA - Marocco 6
AL - Albania 5
AZ - Azerbaigian 5
HU - Ungheria 5
IL - Israele 5
IS - Islanda 5
NZ - Nuova Zelanda 5
PY - Paraguay 5
BG - Bulgaria 4
BO - Bolivia 4
ET - Etiopia 4
GD - Grenada 4
HN - Honduras 4
KE - Kenya 4
BH - Bahrain 3
BY - Bielorussia 3
CZ - Repubblica Ceca 3
GE - Georgia 3
GH - Ghana 3
KZ - Kazakistan 3
LT - Lituania 3
NO - Norvegia 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
AO - Angola 2
BN - Brunei Darussalam 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
LB - Libano 2
LK - Sri Lanka 2
LV - Lettonia 2
OM - Oman 2
PE - Perù 2
PS - Palestinian Territory 2
RS - Serbia 2
TH - Thailandia 2
AD - Andorra 1
BA - Bosnia-Erzegovina 1
BS - Bahamas 1
CG - Congo 1
CI - Costa d'Avorio 1
Totale 11.858
Salva come PNG Salva come JPEG
Città #
Singapore 731
Moscow 631
Ashburn 615
Dallas 571
San Jose 538
Hong Kong 285
Chandler 267
Council Bluffs 188
Verona 185
Dublin 152
The Dalles 123
New York 116
Munich 114
Ho Chi Minh City 104
Beijing 101
Los Angeles 96
Milan 78
Helsinki 77
London 66
Hanoi 65
Rome 54
Jakarta 51
Lappeenranta 51
Lomé 47
Santa Clara 43
Buffalo 40
Cotonou 40
Southend 39
Naples 37
Redondo Beach 37
São Paulo 37
Lawrence 34
Princeton 34
Abuja 33
Houston 31
Bologna 29
Chicago 29
Amsterdam 28
Seattle 28
Tokyo 28
Washington 28
Warsaw 27
Jacksonville 26
Sindelfingen 25
Wilmington 25
Frankfurt am Main 24
Chennai 23
Orem 23
Atlanta 22
Nuremberg 21
Phoenix 21
Venice 20
Mexico City 19
Brooklyn 18
Montreal 18
Istanbul 17
Madrid 16
Sydney 16
Florence 15
Toronto 15
Johannesburg 14
Kuala Lumpur 14
Shanghai 14
Tianjin 14
Boston 13
Mumbai 13
Turin 13
Xi'an 13
Barcelona 12
Enfield 12
Guangzhou 12
Rio de Janeiro 12
Belo Horizonte 11
Brasília 11
Baghdad 10
Columbus 10
Denver 10
Haiphong 10
Manchester 10
Palermo 10
Perth 10
Zurich 10
Brescia 9
Copenhagen 9
Da Nang 9
Dongguan 9
Esslingen am Neckar 9
Genoa 9
Santiago 9
Tashkent 9
Trieste 9
Vienna 9
Jinan 8
Mersin 8
Stockholm 8
Vicenza 8
Ankara 7
Bari 7
Curitiba 7
Falkenstein 7
Totale 6.680
Salva come PNG Salva come JPEG
Nome #
Il ruolo della vitamina D nella dermatite atopica 440
Clinical features and treatments of transient acantholytic dermatosis (Grover’s disease): a systematic review 364
A systematic review of treatments for pityriasis lichenoides 339
Dietary supplements for lipedema 319
Five-year drug survival of dupilumab in atopic dermatitis: Italian landscape AD real-world study 263
Association Between Short-term Exposure to Environmental Air Pollution and Psoriasis Flare 188
BRAF V600E expression in juvenile xanthogranuloma occurring after Langerhans cell histiocytosis. 176
Acquired perforating dermatoses show increased levels of cutaneous advanced glycation end-products 170
Polymorphisms, diet and nutrigenomics 168
Main nutritional deficiencies 163
Impact of the COVID-19 pandemic on melanoma diagnosis 160
Biological disease-modifying antirheumatic drugs may mitigate the risk of psoriatic arthritis in patients with chronic plaque psoriasis 160
Clinical and immunological profile of patients with dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid 157
A dermatologist perspective in the pharmacological treatment of patients with psoriasis and psoriatic arthritis 156
Association between short-term exposure to environmental air pollution and atopic dermatitis flare in patients treated with dupilumab 155
Alopecic and aseptic nodules of the scalp: A new case with a systematic review of the literature 152
Amicrobial Pustulosis of the Folds: Report of Three New Cases 135
Hypochondriasis and Personality Traits of Patients with Chronic Plaque Psoriasis 135
Clinical Characteristics of Patients with Pustular Psoriasis: A Single-Center Retrospective Observational Study 133
Reducing the Risk of Developing Psoriatic Arthritis in Patients with Psoriasis 133
Characteristics of Patients Experiencing a Flare of Generalized Pustular Psoriasis: A Multicenter Observational Study 132
Central Pain Sensitization in Patients with Chronic Plaque Psoriasis 131
Adrenergic urticaria successfully treated with omalizumab 129
Dermoscopic features of nevoid melanoma: a retrospective study 128
Pretibial Dystrophic Epidermolysis Bullosa Successfully Treated with Upadacitinib: A Case Report 127
Cost per Responder Analysis of Secukinumab versus Adalimumab in the Treatment of Psoriatic Disease 127
Coexistence of scleromyxedema and Sneddon syndrome 126
Clinical profile and co-infections of urethritis in males 126
Comparative dermoscopy assessment of nevus-associated versus de novo in situ melanoma 122
Psychological Stress and Salivary Cortisol Levels in Patients with Plaque Psoriasis 122
Diagnosis and Treatment of Infantile Hemangioma from the Primary Care Paediatricians to the Specialist: A Narrative Review 121
Price variability of TNF-α inhibitor biosimilars among European countries 121
Time of Onset of Selected Skin Lesions Associated with COVID-19: A Systematic Review 120
Cost per responder of Adalimumab biosimilars MSB11022 and ABP 501 versus the originator and methotrexate in chronic plaque psoriasis 116
Spesolimab in patients with flare of generalized pustular psoriasis: A multicentre case-series 115
BRAF-Mutated Melanoma Cell Lines Develop Distinct Molecular Signatures After Prolonged Exposure to AZ628 or Dabrafenib: Potential Benefits of the Antiretroviral Treatments Cabotegravir or Doravirine on BRAF-Inhibitor-Resistant Cells 114
The transition from mild to moderate-to-severe chronic plaque psoriasis 114
Clinical‐epidemiological aspects of the Monkeypox 2022 epidemic: a multicenter study by the Italian SIDeMaST Group of Sexually Transmitted, Infectious and Tropical Diseases 113
Real-Life Effectiveness of Adalimumab Biosimilars in Patients with Chronic Plaque Psoriasis 112
Sezary syndrome with large cell transformation and T-follicular helper phenotype 111
Risk of developing psoriatic arthritis in patients with psoriasis initiating treatment with different classes of biologics 110
Upadacitinib in refractory cutaneous pseudolymphoma: A case report 107
Managing the Patient with Psoriasis and Metabolic Comorbidities 105
Methotrexate vs secukinumab safety in psoriasis patients with metabolic syndrome 105
IL-17A inhibitors in patients with chronic plaque psoriasis and history of malignancy: A case series with systematic literature review 104
Certolizumab pegol in severe hidradenitis suppurativa in pregnancy: A case report 103
Persistent localized hypertrichosis in a Caucasian child at sites of DTPa and chickenpox vaccination 103
The safety profile of hydroxychloroquine: major cutaneous and extracutaneous adverse events 101
Consensus on the place in therapy of TNF-a inhibitors in the treatment of patients with chronic plaque psoriasis 101
Primary nodular localized cutaneous amyloidosis of the scalp associated with systemic lupus erythematosus 101
Awareness of obesity among patients with psoriasis 100
Pathogenesis of Chronic Plaque Psoriasis and Its Intersection With Cardio-Metabolic Comorbidities 98
Predictors of subsequent primary melanoma: a case-control study 96
Real-life effectiveness and safety of baricitinib in patients with severe alopecia areata: A 24-week Italian study 95
Cross-Switch from Etanercept Originator to Biosimilar SB4 and to GP2015 in Patients with Chronic Plaque Psoriasis 95
Dupilumab for recalcitrant Kimura disease 95
Optimization of long-range PCR protocol to prepare filaggrin exon 3 libraries for PacBio long-read sequencing 93
Lamivudine, Doravirine, and Cabotegravir downregulate the expression of Human Endogenous Retroviruses (HERVs), inhibit cell growth, and reduce invasive capability in melanoma cell lines 93
Preference for Telemedicine Versus In-Person Visit Among Patients with Psoriasis Receiving Biological Drugs 93
Systematic study on nail plate assessment: differences in nail plate shape, thickness, power Doppler signal and scanning approach 89
Treatment of Psoriasis Patients with Latent Tuberculosis Using IL-17 and IL-23 Inhibitors: A Retrospective, Multinational, Multicentre Study 88
Risk of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis: an updated systematic review and meta-analysis of observational studies 88
Cutaneous Adverse Reactions Associated with SARS-CoV-2 Vaccines 88
Dietary supplements for the management of COVID-19 symptoms 87
Relapse of psoriasis in patients who asked to discontinue etanercept after achieving a stable clinical remission. 87
Generalized pustular psoriasis successfully treated with spesolimab: A case report 86
Biosimilars for the Treatment of Moderate to Severe Chronic Plaque Psoriasis 86
Risk of lymphohematologic malignancies in patients with chronic plaque psoriasis: A systematic review with meta-analysis 86
Enhancing Skin Cancer Prevention and Awareness in the Italian Population: Insights from the “Save Your Skin” Screening Campaign 85
In vitro cell culture of amniotic fluid keratinocytes on amniotic membrane: the ideal tissue for repairing skin ulcers 85
Brodalumab for the treatment of moderate-to-severe plaque-type psoriasis: a real-life, retrospective 24-week experience 84
Immune Response to Vaccination in Patients with Psoriasis Treated with Systemic Therapies 83
The impact of biologic therapy for moderate-to-severe psoriasis on the immune responses to SARS-CoV2 infection and vaccination 82
The Risk of COVID‐19 Pandemic in Patients with Moderate to Severe Plaque Psoriasis Receiving Systemic Treatments 82
Non-Alcoholic Fatty Liver Disease Is Associated With Reduced Glomerular Filtration Rate in Patients With Chronic Plaque Psoriasis 80
Latest Advances for the Treatment of Chronic Plaque Psoriasis with Biologics and Oral Small Molecules 80
Polyphenols and Lactobacillus reuteri in oral health 79
Validating methods for testing natural molecules on molecular pathways of interest in silico and in vitro 79
Monkeypox virus infection: what dermatologist needs to know? 75
Cutaneous Adverse Reactions to SARS-CoV-2 Vaccines: A Systematic Review and Meta-Analysis 75
Skin adverse reactions to Sars‐CoV‐2 vaccination: a relevant responsibility issue for dermatologists 73
Reduction of cutaneous advanced glycation end products levels after effective psoriasis treatment 72
Perforating dermatosis in a young female patient receiving adalimumab biosimilar CTP-17 for chronic plaque psoriasis: A case report 71
Novel loss-of-function variants in filaggrin exon 3 in patients with severe atopic dermatitis 70
Is risankizumab as needed administration a good option for patients with plaque psoriasis? 68
Multi-failure psoriasis patients: characterization of the patients and response to biological therapy in a multicenter Italian cohort 67
X-linked genodermatoses from diagnosis to tailored therapy 66
The Risk of COVID-19 Pandemic in Patients with Moderate to Severe Plaque Psoriasis Receiving Systemic Treatments 63
Neurothekeoma: a pediatric case report and literature review 63
Omics sciences and precision medicine in melanoma 61
Topographic Differential Diagnosis of Chronic Plaque Psoriasis: Challenges and Tricks 61
Long-term follow-up of Zoon balanitis: a retrospective cohort study 59
Use of biologics during the COVID-19 pandemic: lessons learned from psoriasis 59
Prevalence of Non-Alcoholic Fatty Liver Disease in Adult Individuals with Moderate-to-Severe Atopic Dermatitis 57
Psoriasis: talking points from recent clinical trials 57
Could Targeted Pharmacotherapies Exert a "Disease Modification Effect" in Patients with Chronic Plaque Psoriasis? 57
Disease Severity Is Associated with Alexithymia in Patients with Atopic Dermatitis 56
Super Responder Profle Under Bimekizumab Treatment in Moderate‐to‐Severe Psoriasis: A Short Term Real‐Life Observation—IL PSO (Italian Landscape Psoriasis) 54
Scurvy as Presenting Sign of Anorexia Nervosa 54
Bluish-Green Coloration of the Nipples: A Diagnostic Clue for Retroareolar Cysts 52
Totale 11.385
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.330
article - articoli 47.330
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 94.660
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022212 0 27 4 12 31 12 15 16 11 12 17 55
2022/20231.126 38 72 63 144 63 203 15 53 210 157 78 30
2023/2024940 59 64 97 102 82 166 67 57 16 44 108 78
2024/20252.473 119 104 125 379 118 145 227 112 376 192 167 409
2025/20266.754 423 480 439 870 1.731 378 682 468 470 392 162 259
2026/2027372 323 49 0 0 0 0 0 0 0 0 0 0
Totale 12.025